BioMarin to Attend Three Upcoming Investor Conferences

SAN RAFAEL, Calif., Oct. 31, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. BMRN today announced that management will participate in Credit Suisse's 26^th Annual Healthcare Conference on November 7, 2017 at 9:10am MT/11:10am ET, in Scottsdale, Arizona, the Stifel 2017 Healthcare Conference on November 14, 2017 at 10:15am ET in New York and the Evercore ISI Biopharma Catalyst/Deep Dive Conference on November 29, 2017 at 11:00am ET in Boston.  To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

View original content with multimedia:http://www.prnewswire.com/news-releases/biomarin-to-attend-three-upcoming-investor-conferences-300542649.html

SOURCE BioMarin Pharmaceutical Inc.